Please use this identifier to cite or link to this item: https://doi.org/10.1002/clt2.12122
Title: Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID-19 pandemic: A multicenter, two-arm, real-world study
Authors: Zhou, S
Liu, Y
Xue, J
Tang, J
Yu, Q
Qu, S
Zhang, S
Mo, B
Li, J
Liu, Y
Yang, Y
Wang, DY 
Qiu, Q
Keywords: COVID‐19
delayed therapy
depression
efficacy
subcutaneous immunotherapy (SCIT)
Issue Date: 1-Mar-2022
Publisher: Wiley
Citation: Zhou, S, Liu, Y, Xue, J, Tang, J, Yu, Q, Qu, S, Zhang, S, Mo, B, Li, J, Liu, Y, Yang, Y, Wang, DY, Qiu, Q (2022-03-01). Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID-19 pandemic: A multicenter, two-arm, real-world study. Clinical and Translational Allergy 12 (3) : e12122-. ScholarBank@NUS Repository. https://doi.org/10.1002/clt2.12122
Source Title: Clinical and Translational Allergy
URI: https://scholarbank.nus.edu.sg/handle/10635/227542
ISSN: 20457022
DOI: 10.1002/clt2.12122
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to .pdfPublished version370.49 kBAdobe PDF

OPEN

PublishedView/Download

Page view(s)

31
checked on Sep 22, 2022

Download(s)

1
checked on Sep 22, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.